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Deciphering the mechanism by which the relative
Ab42(43) to total Ab ratio is regulated is central to
understanding Alzheimer disease (AD) etiology;
however, the mechanisms underlying changes in
the Ab42(43) ratio caused by familial mutations and
g-secretase modulators (GSMs) are unclear. Here,
we show in vitro and in living cells that presenilin
(PS)/g-secretase cleaves Ab42 into Ab38, and Ab43
into Ab40 or Ab38. Approximately 40% of Ab38 is
derived from Ab43. Ab42(43) cleavage is involved in
the regulation of the Ab42(43) ratio in living cells.
GSMs increase the cleavage of PS/g-secretase-
bound Ab42 (increase kcat) and slow its dissociation
from the enzyme (decrease kb), whereas PS1
mutants and inverse GSMs show the opposite
effects. Therefore, we suggest a concept to describe
the Ab42(43) production process and propose how
GSMs act, and we suggest that a loss of PS/g-secre-
tase function to cleave Ab42(43) may initiate AD and
might represent a therapeutic target.
INTRODUCTION
Alzheimer disease (AD) amyloid-b42 peptide (Ab42) and Ab43
are generated from b-amyloid protein precursor (bAPP) and
accumulate in senile plaques (Gravina et al., 1995). Because
Ab is secreted as multiple peptide species with different C
termini, intramembrane proteolysis of Ab by presenilin (PS)/g-
secretase (De Strooper et al., 1998, 1999; Sherrington et al.,
1995; Struhl and Greenwald, 1999; Wolfe et al., 1999) does not
occur at a unique site. However, because even small elevations
in the ratio of Ab42(43) to total Ab (Ab42[43] ratio) in secreted Ab
by PS or bAPP mutations trigger familial AD (Kuperstein et al.,
2010; Scheuner et al., 1996; Suzuki et al., 1994), the proteolysis
is regulated strictly in this aspect. How the variation in Ab is
generated remains unclear.
How bAPP-CTF is cleaved into Ab42 is controversial because
of conflicting findings. First, cleavage at the ε-site generates42 Cell Reports 3, 42–51, January 31, 2013 ª2013 The Authorsprimarily long fragments, namely Ab48 and Ab49, and is followed
by stepwise cleavage of every three amino acid residues starting
at the C terminus (Qi-Takahara et al., 2005). Two distinct lines
have been proposed for Ab40 and Ab42 production. Second,
cleavage at the g-site does not correlate directly with cleavage
at the ε-site (He et al., 2010).
The ratio of APL1b28, a surrogate marker of Ab42, to total
APL1b is elevated in the cerebrospinal fluid of patients with
sporadic AD, including those in the mild cognitive impairment
stage and in those with familial AD (Yanagida et al., 2009).
Thus, an increase in the Ab42 ratio in the brain may play a role
in the etiology of most AD cases, and the mechanism underly-
ing the regulation of the Ab42 ratio is a central issue in under-
standing AD.
g-Secretase modulators (GSMs) are disease-modifying drugs
that specifically reduce Ab42 generation (Kounnas et al., 2010;
Weggen et al., 2001); some GSMs are being studied in clinical
trials. Despite the development of GSMs (Wolfe, 2012), their
mechanism of action (Cha´vez-Gutie´rrez et al., 2012) remains
unclear.
Given that the VVIA peptide located between the g38 and g42
cleavage sites was detected in an in vitro bAPP-CTF cleavage
assay (Takami et al., 2009), we asked whether Ab42(43), formerly
considered a product of PS/g-secretase, could also be a
substrate for PS/g-secretase. Here, we show that Ab42(43) is
an intermediate of PS/g-secretase, a finding that provides
important insight into the regulation of the Ab42(43) ratio. Our
results will help elucidate the mechanism underlying the actions
of GSMs and PS mutants.
RESULTS
AD-Associated Ab42 Is a Substrate of PS/g-Secretase
Initially, we performed a modified in vitro g-secretase assay in
which we used CHAPSO (3-[(3-Cholamidopropyl)dimethylam-
monio]-2-hydroxypropanesulfonate) at its critical micelle con-
centration of 0.5% instead of 0.25%, the concentration used in
the original method (Li et al., 2000). We experimented with using
Ab42 as a substrate instead of the bAPP-C-terminal fragment
(bAPP-CTF) (Cha´vez-Gutie´rrez et al., 2012). Surprisingly, Ab38
was generated de novo from Ab42 by PS/g-secretase, a process
that we refer to as ‘‘Ab42 cleavage’’ (Figure 1). MALDI-TOFmass
Figure 1. Detection of Ab and Related Small Peptide Species
Ab42 and bAPP-CTF cleavage assays were performed at 37C for 30 min.
(A) Immunoprecipitation-MSanalysisofproducts from theAb42cleavageassay.
(B) Small Ab-derived peptides (Takami et al., 2009) detected in the Ab42
cleavage assay.
(C) Levels of total Ab from bAPP-CTF (black line) and Ab38 generated from
Ab42 (red line) at various CHAPSO concentrations (0%–1.5%).
(D) Immunoprecipitation-immunoblot detection of Ab. The volume of each
reaction for immunoprecipitation was adjusted to contain the same amount of
total Ab.
(E) Relative rate of the VVIA produced in (D), as defined by [VVIA]/[TVI]. The
actual individual data from each of the three experiments are plotted.
See also Figures S1, S2, and S4.spectroscopy (MS) showed a de novo product of 4132.6 Da,
which matches ionized Ab38 (Figure 1A). Liquid-chromatog-
raphy tandem MS (LC-MS/MS) (Takami et al., 2009) showed
high levels of VVIA tetrapeptide between Ab38 and Ab42 (Fig-
ure 1B). No further cleavage of Ab38 was observed, indicating
that Ab38 was the final product (Figure S1A). We also observed
a small amount of VIA (1/40th the amount of VVIA), the tripep-
tide between Ab39 and Ab42, indicating very low-level produc-
tion of Ab39 (Figure 1B). Cleavage of Ab42 was eliminated by
g-secretase inhibitors (Figures 1A and 1B). We also found that
the N terminus of the substrate Ab42 was not necessarily the first
residue, because Ab11–42 was also cleaved (Figure S1B).
Collectively, these results indicate that Ab42 is cleaved into
Ab38 and Ab39. Irrespective of how cleavage at the g42-site
occurs (Qi-Takahara et al., 2005; He et al., 2010), our current
results demonstrate that Ab42, the pathological PS/g-secretase
product, is also a substrate for PS/g-secretase.
We next studied Ab42 cleavage, when bAPP-CTF is the
substrate. Cleavage of Ab42 in the new assay was optimal at
0.5%CHAPSO,whereas cleavage of bAPP-CTF in the conven-
tional assay was optimal at0.2%CHAPSO (Li et al., 2000) (Fig-
ure 1C). Given this result, we considered the possibility that the
Ab42 ratio in the de novo Ab generation in the bAPP-CTF
cleavage assay might decrease at a higher CHAPSO concentra-
tion (0.5%). As the CHAPSO concentration increased, the rela-
tive ratio of Ab42(43) production decreased and the ratio of Ab38
production increased (Figure 1D; Figure S2A). Surprisingly, the
relative ratio of Ab42(43) to Ab40 was 0.1 at 0.5% CHAPSO.
Thus, we suspected that the much higher Ab42(43) ratio
produced in the conventional bAPP-CTF cleavage assay than
that secreted from living cells may be because the assay was
performed in the presence of 0.25% CHAPSO. In this regard,
the in vitro g-secretase assay in the presence of 0.5%
CHAPSO may be a better model.
Because Ab42 levels are determined by the balance between
its rate of production and its rate of degradation, we measured
further the levels of small peptides produced by bAPP-CTF
cleavage (Figure 1E). The relative amount of VVIA produced by
bAPP-CTF cleavage increased as the Ab38 ratio increased.
These data suggest that the relative levels of Ab42 are also
a function of Ab42 cleavage. Moreover, CTFg38/40/42/43, the
counterparts of direct cleavage at the Ab38/40/42/43 sites,
have never been observed (Gu et al., 2001). Collectively, our
results indicate that Ab42 is an intermediate stopover product
of the cleavage of bAPP-CTF by PS/g-secretase.
GSMs and Mutant PS1/g-Secretases Increase and
Decrease Ab42 Cleavage in Living Cells, Respectively
Next, we asked whether the Ab42 cleavage process plays a
role in conditions where the Ab42 ratio in secreted Ab changes
in vitro and in living cells. First, we examined whether GSMs
and inverse GSMs (iGSMs) (Kukar et al., 2005) change the rate
of Ab42 cleavage in vitro when the enzyme activity is low
(0.25% CHAPSO) or high (0.5% CHAPSO). Strikingly, in the
presence of 0.25% CHAPSO, all GSMs tested (GSM1, Eisai,
Compound W, and Sulindac sulfide) increased the relative rate
of Ab42 cleavage (Figure 2A; Table S1A). In contrast, in the pres-
ence of 0.5% CHAPSO, the iGSMs tested (fenofibrate andCell Reports 3, 42–51, January 31, 2013 ª2013 The Authors 43
Figure 2. Effects of GSMs/iGSMs and Mutant PS1/g-Secretases on Ab42 Cleavage
(A) Fold activation of Ab42 cleavage by GSMs/iGSMs in the presence of 0.25% CHAPSO. We extracted the PS/g-secretase fraction from HEK cells stably
expressingWT PS1 (Figure S2B). A total of 40 mMGSM1, 10 mMEisai, 10 mMcompound-W (CW), 10 mMSS, 50 mM fenofibrate (FF), or 10 mMS2474was added to
the in vitro assay.
(B) Fold activation of Ab42 cleavage by GSMs/iGSMs in the presence of 0.5% CHAPSO.
(C) Fold changes of the relative VVIA levels in cell lysates treated with GSMs/iGSM. A total of 4 mMGSM1, 1 mMEisai, or 30 mM S2474 was added to the cultured
medium.
(D) The relative ratio of Ab species in conditioned medium. The levels of Ab38, Ab40, and Ab42 were measured by ELISA.
(E) Immunoblotting of purified PS/g-secretase fractions. To show that the same level of each mutant PS1/g-secretase was used in each reaction, we
immunoblotted each fraction with antibodies against all four indispensable elements of PS1/g-secretase: PS1/2, nicastrin, APh-1-a, and PEN-2. We detected
almost equal band densities for all four proteins of mutants andWT PS1/g-secretase fractions. Exogenous PS1 derivatives displaced the endogenousWT PS2 in
the PS/g-secretase complex. Note that a certain mutant contained a higher level of nicastrin, and thus was omitted from the analysis.
(F) Fold activation of Ab42 cleavage by purified mutant PS1/g-secretase.
(G) Fold changes of the relative VVIA levels in cell lysates stably expressing PS1 mutants.
(H) The relative ratio of Ab species in conditioned medium.
The Ab38 level was measured by ELISA. Asterisks indicate p < 0.05, Welch’s t test. Error bars represent SD. The actual individual data from each of the three
experiments are plotted in (A), (B), and (F). See also Figures S1 and S2.
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S2474) decreased the relative rate of Ab42 cleavage (Figure 2B;
Table S1B).
We do not know how CHAPSO affects the rate of Ab42
cleavage in vitro. However, in the presence of 0.25% CHAPSO,
when Ab42 cleavage activity is low, iGSMs did not slow the
reaction (Figure 2A). Similarly, GSMs did not increase Ab42
cleavage in the presence of 0.5% CHAPSO, when the activity
is high (Figure 2B). These findings suggest that the effects of
CHAPSO and GSMs/iGSMs are related.
Next, we investigated whether an increase in Ab42 cleavage
byGSMs is responsible for the decrease in the Ab42 ratio in living
cells. We added GSMs and iGSMs to cultured HEK cells ex-
pressing wild-type (WT) and Swedish mutant (sw) bAPP stably,
which were the same cell lines used for extracting PS1/g-secre-
tase for the in vitro experiments. We immediately boiled the
treated cells for 2 min to inhibit completely the active degrada-
tion of tri-, tetra-, and pentapeptides in the living cells. We ex-
tracted the soluble fraction from the resultant cell lysate and
measured the levels of the small peptides by LC-MS/MS (Figures
2C and 2G).
Hereafter, the mention of an increase or a decrease in the
levels of each peptide associatedwith the generation of secreted
forms of Ab (e.g., VVIA, VVIAT, and IAT) implies that the relative
ratio of a peptide was calculated in relation to that of the sum
of peptides associated with Ab generation (i.e., ITL, VIT, VIV,
TVI, IAT, VVIA, and VVIAT) (Figures 2, 3, and 4). GSM-treated
cells, which secreted a lower ratio of Ab42 (Figure 2D; Table
S1D), contained a higher ratio of VVIA (produced by cleavage
of Ab42 into Ab38) than did DMSO-treated cells (Figure 2C;
Table S1C). In contrast, iGSM-treated cells, which secreted
a higher ratio of Ab42 (Figure 2D), contained a lower ratio of
VVIA (Figure 2C). These data indicate that GSMs and iGSMs
increase and decrease, respectively, the rate of Ab42 cleavage
in living cells.
Next, because the Ab42 ratio in secreted Ab is increased in
most PS1 pathological mutants (Scheuner et al., 1996), we
examined whether PS1 mutants integrated into the PS/g-secre-
tase complex exhibit a reduced rate of Ab42 cleavage. We
extracted the PS/g-secretase fraction (Figure 2E; see also
Figures S2F and S2B–S2D) (Winkler et al., 2009) from HEK cells
stably expressing WT or mutant (L286V, L381V, or G384A) PS1
(Figures S2E and S2F). The same amount of enzyme complex
was included in each reaction (Figure 2E). We found that the
rate of Ab42 cleavage was lower for mutant than for WT PS1/
g-secretase (Figure 2F; Table S1E), which is consistent with
a previous report (Cha´vez-Gutie´rrez et al., 2012). The results
are reminiscent of the fact that cells expressing mutant PS1/g-
secretases generally secrete less total Ab than do WT cells
(Shen and Kelleher, 2007). However, it is of note that the reduced
rate of Ab42 cleavage described here is different from the overall
loss of function of PS/g-secretase.
We investigated whether reducing Ab42 cleavage by mutant
PS/g-secretases could increase the Ab42 ratio in living cells.
We cultured WT or mutant PS1-expressing cells coexpressing
sw bAPP (the same cell line used for the in vitro experiments)
and analyzed the cell lysates by LC-MS/MS. The relative levels
of VVIA were lower in the lysates of mutant cells than in WT cells
(Figure 2G; Table S1F). We confirmed the increased Ab42 ratio inthe conditioned medium of the mutant-expressing cells (Fig-
ure 2H; Table S1F). These data demonstrate that mutant PS1/
g-secretases decrease the rate of Ab42 cleavage in living cells.
Collectively, our data suggest that the Ab42 cleavage process
is associated with the Ab42 ratio in secreted Ab.
A New Concept for the Production of Bona Fide Ab42
To gain insight into the regulation of Ab42 cleavage, we next
examined how GSMs, iGSMs, and mutant PS1/g-secretases
alter Ab42 cleavage activity in vitro. The conversion of Ab42
into Ab38 can be described by the following scheme and with
the following rate constants:
½PS=g secretase+ ½Ab42%ka
kb
½PS=g secretase=
Ab42 complex/kcat ½Ab38+ ½PS=g secretase
This equation can be applied to the production of ‘‘free Ab42’’
from de novo Ab42 (shown in the diagram in Figure 3A). Escape
from further cleavage and production of free Ab42 both require
that the de novo-generated bound Ab42 dissociates from PS/
g-secretase. We suggest this concept to explain the production
of bona fide Ab42. According to the model, kcat (unimolecular
rate constants) and kb (dissociation rate constants) values would
be relevant to the generation of free Ab42.
One may think that once bAPP-CTF and PS/g-secretase form
a complex, intermediate long Ab does not dissociate from the
enzyme during the stepwise cleavages. According to the model,
the kcat values of the Ab42 cleavage should vary depending on
the substrate. However, without any changes in the relative posi-
tion of long Ab species to PS/g-secretase, the stepwise cleav-
ages might be interrupted. Moreover, we showed clearly that
Ab42, Ab43, Ab45, and Ab46 can bind to PS/g-secretase and
undergo cleavage (Figures 1 and 4). It is unknown whether all
of the intracellular Ab45 and Ab46 (Qi-Takahara et al., 2005)
bind to PS/g-secretase. Based on these findings, we suggest
that the long Ab species undergoes association/dissociation
events with PS/g-secretase. Therefore, we revised the formulas
describing the stepwise cleavage process proposed originally by
Takami et al. (2009) (Figure 3B). We introduced the association/
dissociation steps clearly for each cleavage step and did not
consider that the cleavage at every three amino acid residues
is an essential part of the cleavage process. Ab42 and Ab43
correspond to AbXn in the revised scheme. Ab45 and Ab46 corre-
spond to AbX(n-1). Whether the various free AbXn products
produced in each step remain at themembrane depends on their
physicochemical nature. According to our model, the kcat values
of the Ab42 cleavage should be the same, regardless of the
substrate (e.g., bAPP-CTF and Ab42).
GSMs and Mutant PS1 Increase and Decrease,
Respectively, the Velocity at which Bound Ab42 Is
Cleaved to Ab38 In Vitro
First, to obtain the relative kcat values for Ab42 cleavage, we per-
formed enzyme kinetic analysis of Ab42 cleavage over a range of
Ab42 concentrations (Figures 3C–3E; see also Tables S2A–
S2C). The Ab42 cleavage reaction conformed to Michaelis-Cell Reports 3, 42–51, January 31, 2013 ª2013 The Authors 45
Figure 3. Enzyme Kinetic Analysis of Ab42 Cleavage and Biacore Analysis of Ab42 Dissociation from PS1/g-Secretase
(A) Proposed reaction mechanism for Ab42 production.
(B) Proposed formulas of stepwise cleavage for Ab production.
(C) Hanes-Woolf plots of the Ab42 cleavage in the presence of 0.25%CHAPSO and GSMs (DMSO, black diamonds; GSM1, green squares; Eisai, blue triangles).
(legend continued on next page)
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Menten kinetics (Figures S3A–S3D). Next, we examined whether
GSM or iGSM alters the kcat for Ab42 cleavage. Hanes-Woolf
plots were used to determine the Vmax values (Figures 3C, 3D,
and 3F). Because Ab42 was in excess in the reactions, we
assumed that Vmax = kcat [PS/g-secretase]. The relative kcat
value was larger in the presence of GSM1 or Eisai than with
WT PS/g-secretase alone, whereas the value was smaller in
the presence of S2474 than with WT PS/g-secretase (Figure 3E;
Table S2C). Depending on CHAPSO concentration (0.25% or
0.5%), the y intercepts of the Hanes-Woolf plots differed, indi-
cating that CHAPSO noncompetitively modified the action of
PS/g-secretase. We next performed reactions using equal
amounts of each mutant and WT PS1/g-secretase (Figure 3F;
Table S2D). The relative kcat values were smaller for PS1
L286V, L381V, and G384A/g-secretase than for WT PS/g-secre-
tase (Figure 3G; Table S2E). Thus, in the assay conditions used,
GSMs increased the velocity at which bound Ab42 was cleaved
to Ab38, whereas both PS1 mutants and iGSM reduced the
velocity of the cleavage.
A GSM Reduces the Velocity at which Bound Ab42
Dissociates fromWT PS1/g-Secretase, but the Complex
of Mutant PS1/g-Secretases and Ab42 Dissociates
Faster
We also used Biacore binding analysis to measure the relative
dissociation rate constant kb for the complex of Ab42 bound to
PS1/g-secretase. Ab42 was immobilized to the sensor tip, and
purified PS1/g-secretases were injected as the analytes. We
tried tomeasure the kb values to show how fast Ab42 dissociates
from the active center of PS/g-secretase. We performed the Bia-
core assay with PS/g-secretase preincubated in the presence or
absence of L685,458, a transition state mimic that blocks the
active site of PS/g-secretase (see Figures S3E–S3J). We
assumed that subtracting the resonance unit (RU) value for the
L685,458–PS/g-secretase complex binding to Ab42 from the
RU value for PS/g-secretase alone (without mixing with
L685,458) binding to Ab42would give the RU value for PS/g-sec-
retase, which holds Ab42 in its active center (see Figures 3H and
3J). Using the RU values, we calculated kb values for the disso-
ciation of the bound Ab42 from the active center.
We studied whether GSM1 or S2474 affects the kb value.
During the period from 5 s to 155 s in the dissociation phase,
the washout curves of compounds tested with Ab42 showed
simple one-step dissociation with the single exponential rate ex-
pected from the model (Figure 3H; Table S2F). The relative kb
values of dissociation in the presence of GSM1 and S2474
were smaller and larger, respectively, than the value for WT(D) Hanes-Woolf plots of Ab42 cleavage in the presence of 0.5% CHAPSO and i
(E) The relative kcat values (n = 4) of Ab42 cleavage in the presence of GSMs/iGS
(F) Hanes-Woolf plots of Ab42 cleavage byWT and mutant PS1/g-secretase (WT
G384A, purple crosses) in the presence of 0.5% CHAPSO.
(G) The relative kcat values of Ab42 cleavage by WT and mutant PS1/g-secretase
(H) Fitted curves of dissociation for DMSO (purple/black), GSM1 (18 mM, green/g
(I) kb values (n = 3 for each) in the presence of GSM/iGSM treatment compared
(J) Fitted curves of dissociation (WT PS1/g-secretase, blue/black; PS1 L286V/g-
(K) kb values of mutant PS1/g-secretases relative to those of WT PS1/g-secretas
Asterisks indicate p < 0.05, Welch’s t test. Error bars represent SD. See also FigPS/g-secretase alone (Figure 3I; Table S2G). The results indicate
that GSM1 and S2474 decreased and increased the rate of
dissociation of Ab42 from the active center of PS/g-secretase
by 0.36 and 2.7 times, respectively, compared with the DMSO
control in the assay condition. We also performed similar exper-
iments to measure the relative kb values for the complex of Ab42
with WT and mutant PS1/g-secretase (Figure 3J; Table S2H).
The dissociation rates of Ab42 from L286V and G384A mutant
PS1/g-secretases were 2.4 and 2.0 times larger, respectively,
than the rate for WT PS1/g-secretase (Figure 3K; Table S2I).
These data suggest that the velocity at which bound Ab42 disso-
ciates from PS1/g-secretase contributes to the changes in the
Ab42 ratio in secreted Ab caused by the compounds and some
mutants. However, we are not yet able to show the extent of
the relative effects of the two factors (i.e., kcat and kb) when the
Ab42 ratio changes in living cells.
Ab43, Another Long Ab Species, Is Cleaved into Ab40
or Ab38 by PS/g-Secretase in Living Cells
Ab43 is another long species of Ab (Saito et al., 2011). We also
investigated whether Ab43 undergoes further proteolysis in
a manner similar to Ab42. MALDI-TOF MS (Figure 4A) and LC-
MS/MS (Figure 4B) showed that Ab43 was cleaved to Ab40 or
Ab38 by PS/g-secretase in vitro. Thus, Ab38 hasmultiple precur-
sors. This was confirmed by the in vitro bAPP-CTF cleavage
assay (Figure 4C). Why PS/g-secretase cleaved the substrate
at only one of two sites remains unclear. The production of
Ab37 and GVV indicates minor but further cleavage of de novo
Ab40 (Figures 4A and 4B; Figures S1C and S1D).
We measured the amounts of tri-, tetra-, and pentapeptides
produced during the stepwise processing of bAPP in living cells
(Figure 4D; Figure S4A). Approximately 40% of Ab38 was
derived from Ab43 (Table S3A). GSMs increased the relative
rate of Ab43 cleavage into Ab38 (i.e., the level of VVIAT relative
to that of total Ab-related small peptides) (Figure 4E; Table
S3B), whereas iGSM and mutant PS1/g-secretases decreased
the rate (Figure 4E and 4F; Table S3C). These results are very
similar to the effects of the compounds and the mutants on
Ab42 cleavage (see Figures 2C and 2G; summarized in Figures
4I and 4J). However, both the tested GSM/iGSM (Figure 4G;
Table S3D) and some mutant PS1/g-secretases (i.e., PS1
L381V and G384A) (Figure 4H; Table S3E) decreased the rate
of Ab43 cleavage into Ab40 (i.e., IAT). Thus, the cleavage of
Ab43 into Ab38 and that into Ab40 were affected differently by
GSMs.
Next, we asked whether the relative level of Ab38 derived from
Ab42 and that derived from Ab43 (i.e., VVIA and VVIAT) in livingGSM (DMSO, black diamonds; S2474, red squares).
M.
PS1, black diamonds; PS1 L286V, red triangles; PS1 L381V, blue squares; PS1
.
ray), and S2474 (135 mM, blue/red).
with those obtained in the presence of DMSO treatment.
secretase, purple/red; PS1 G384A/g-secretase, green/gray).
e.
ure S3.
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cells could be changed by the compounds and mutants. GSMs
drastically increased the relative levels of both VVIA and VVIAT,
whereas an iGSMs decreased the relative levels of the two
peptides (Figure 4I; Table S3F). Notably, because of the GSM
effect, more than half of the Ab38 was derived from Ab43. The
PS1 mutants decreased the relative levels of VVIA and VVIAT;
however, the degree of the changes was much smaller than
that observed for GSM (Figure 4J; Table S3G). The PS1 G384A
mutant did not decrease the relative levels of VVIAT. Very similar
data were obtained when the levels of VVIA and VVIAT were
normalized to the level of each major cleavage in the previous
step (i.e., TVI for VVIA and VIV for VVIAT; Figures S4B and
S4C). Collectively, these results indicate that GSMs strongly
affect Ab42(43) cleavage, and the increase in Ab38 production
is largely attributed to the cleavage of Ab43 into Ab38.
We also performed an Ab45 and Ab46 cleavage assay.
MALDI-TOF MS showed that both Ab45 and Ab46 were cleaved
by PS/g-secretase. Interestingly, Ab41 and Ab40, in addition to
Ab42, were produced from Ab45. Ab42, in addition to Ab43,
was produced from Ab46 (Figures 4K and 4L). Combined with
the results showing that considerable amounts of Ab38 were
derived from Ab43, the data indicate that the proposed ‘‘Ab38
product line’’ (from bAPP-CTF via Ab48 and Ab42) and the
proposed ‘‘Ab40 product line’’ (from bAPP-CTF via Ab49 and
Ab43) (Takami et al., 2009) cross each other.
We studied how the CHAPSO concentration affects the rates
of Ab42(43) cleavage, when bAPP-CTF is cleaved in vitro
(Figures S4D and S4E). Interestingly, CHAPSO affected the rates
in a dose-dependent manner and in a similar way to the effect of
GSMs.
Long Ab-like Peptides Other Than Ab Are Also
Substrates of PS/g-Secretase
Ab-like peptides (Okochi et al., 2002), secreted by a process
similar to that for Ab secretion, include mNotch-1-derived Nb
(Okochi et al., 2006) and APLP1-derived APL1b (Yanagida
et al., 2009). We found that PS/g-secretase cleaved Nb25 into
Nb21 (Figure 4M) and APL1b28 into APL1b25 (Figure 4N), sug-Figure 4. Cleavage of Ab43, Nb25, and APL1b28 by PS/g-Secretase
(A) Representative MALDI-TOF MS spectrum from the Ab43 cleavage assay (0.5
(B) Ab-derived peptides in the Ab43 cleavage assay. Addition of L685,458 abolish
IAT and VVIAT than that of VVIA produced by Ab42 cleavage. This may be due to
et al., 2011).
(C) Ab species by the bAPP-CTF cleavage assay in the presence of 0.25% or 0.5
(D) Ab species in lysates of HEK293 cells in a 10 cm dish stably expressing sw b
(E) Fold changes of the relative VVIAT levels in cell lysates treated with GSMs/iG
(F) Fold changes of the relative VVIAT levels in lysates from cells stably expressi
(G) Fold changes of the relative IAT levels in cell lysates treated with GSMs/iGSM
(H) Fold changes of the relative IAT levels in lysates from cells stably expressing
(I) The relative rates of VVIA (blue) and VVIAT (red) in cells treated with GSMs/iG
(J) The relative rates of VVIA (blue) and VVIAT (red) in cells stably expressing PS
(K) Representative MALDI-TOF MS spectrum of products from the Ab45 cleavag
(L) Representative MALDI-TOF MS spectrum of products from the Ab46 cleavag
(M) Nb25 cleavage assay (0.5% CHAPSO).
(N) APL1b28 cleavage assay (0.5%CHAPSO). Insets show an enlargement of the
than Nb25 cleavage and Ab42 cleavage.
Asterisks in (A), (K), (L), and (N) indicate nonspecific peaks, and those in (E), (F), (G
also Figures S1 and S4.gesting that long Ab-like peptides are generally intermediate
products. This may explain why the relative levels of some longer
secreted Ab-like peptides, including Ab42, change in parallel
(Okochi et al., 2006; Yanagida et al., 2009). This finding also indi-
cates that APL1b28 cleavage to APL1b25 is impaired in the
sporadic AD brain (Yanagida et al., 2009).
DISCUSSION
In this study, we show that de novo Ab42(43), a secreted species,
is an intermediate of PS/g-secretase in living cells, and this
discovery affects the understanding of the nature of Ab42(43)
production. We suggest that Ab42 production does not directly
reflect the level of cleavage at the C terminus of Ab42, but rather
depends on how much newly produced Ab42 dissociates
from the PS/g-secretase enzyme and thereby avoids further
cleavage. Thus, competition between further cleavage and
dissociation from the enzyme may be the key to determining
the Ab42(43) ratio. Importantly, our results also suggest that
a new type of partial loss of function in PS/g-secretase [e.g.,
reduction in Ab42(43) cleavage or at the final step of PS/g-secre-
tase cleavage of bAPP] may cause a gain of function in AD [an
increase in the Ab42(43) ratio]. GSMs increase the relative kcat
for the further cleavage of Ab42 to Ab38 and decrease the rela-
tive kb for the dissociation of Ab42 from PS1/g-secretase. This
suggests a potential model to explain how GSMs can lower
Ab42 production.
Cha´vez-Gutie´rrez et al., 2012 showed that PS1 mutations
lower the relative levels of Ab38 to Ab42 and Ab40 to Ab43
compared with WT PS1. The GSMs tested increased both the
level of Ab38 relative to Ab42 (Weggen et al., 2001) and the level
of Ab40 relative to Ab43. Based on the hypothetical model
proposed by Ihara and colleagues (Takami et al., 2009), those
authors speculated that the PS1 mutants and GSMs decrease
and increase, respectively, the rate of the fourth cleavage (i.e.,
Ab43 cleavage to Ab40 and Ab42 cleavage to Ab38, respec-
tively), possibly because of the premature release of the Ab42/
Ab43 peptides.% CHAPSO).
ed their generation. Note that Ab43 cleavage produced much smaller levels of
the fact that the aggregation property of Ab43 is higher than that of Ab42 (Saito
% CHAPSO.
APP and WT PS1.
SMs.
ng PS1 mutants.
s.
PS1 mutants.
SMs.
1 mutants.
e assay (0.25% CHAPSO).
e assay (0.75% CHAPSO).
part encircled by the dotted line. Note that APL1b28 cleavage was less efficient
), (H), (I), and (J) indicate statistical significance. Error bars represent SD. See
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We found that, in living cells, 40% of Ab38 was derived from
Ab43. Moreover, Ab40 and Ab41 were produced in the Ab45
cleavage assay, and Ab42 was produced in the Ab46 cleavage
assay. Thus, the putative Ab38 and Ab40 product lines (Takami
et al., 2009) turn out to overlap at several points.
Takami et al. (2009) showed that Sulindac sulfide decreased
the levels of Ab42 and Ab43 in a bAPP-CTF cleavage assay,
but did not significantly increase the levels of VVIA and IAT.
This may be because Sulindac sulfide exerts a weaker GSM
action than GSM1 and Eisai, which were used in this study.
We also found that Notch-1 and APLP1 transmembrane
domains are cleaved in a similar way, which should help clarify
the physiological process of intramembrane proteolysis by PS/
g-secretase. We showed previously that Ab42 ratio changed in
parallel with APL1b28 ratio, and that the APL1b28 ratio increases
in the cerebrospinal fluid of AD patients (Yanagida et al., 2009).
In this article, we demonstrated that both Ab42 and APL1b28
were cleaved similarly into the shorter species (i.e., Ab38 and
APL1b25). Therefore, we suggest that Ab42 cleavage may also
decrease in AD brains.
Collectively, we speculate that the increase in the Ab42 ratio
simply reflects the accelerated dissociation ofmembrane-bound
long Abs (ie, Ab4449) from PS/g-secretase. Because long Abs
on the membrane may perturb the physiological function of
neuronal cells, further studies are necessary to investigate
whether the prolonged stay of long Ab at the membrane is path-
ologically relevant.
At present, inhibition of PS/g-secretase activity using agents
such as Notch-sparing inhibitors is the central approach to
decreasing Ab production specifically. Our results may shift the
nature of new drugs for treating AD to repair or increase the
ability of PS/g-secretase to cleave Ab42(43).
EXPERIMENTAL PROCEDURES
Ab and Ab-like Peptide Cleavage Assays
In vitro g-secretase assays (Li et al., 2000; Osawa et al., 2008) using Ab and
Ab-like peptides (Ab42, 43, 45, 46, Nb25, and APL1b28) were performed under
the modified conditions described here with a modified reaction buffer
(150 mM citrate buffer [pH 6.0], 0.25 M sucrose, 0.04%–1.5% CHAPSO,
0.1% phosphatidylcholine, 10 mM bestatin, 10 mM amastatin, 5 mM phenan-
throline, 10 mM captopril, and 53 Roche protease inhibitor mix).
Extraction of Tri-, Tetra-, and Pentapeptides from Living Cultured
Cells
HEK cells stably expressing sw bAPP and PS1 derivatives were cultured to
confluence in 10 cm dishes, and 24 hr before collection, the cells were treated
with GSM or iGSM. Proteasome inhibitors (1 mM lactacystin, 100 nM MG262,
and 1 mM epoxomicin) were added, with or without GSM/iGSM, to the
conditioned medium for the last 4 hr. The cells were washed quickly with
ice-cold PBS and then immediately boiled for 2 min. The boiled samples
were sonicated for 5 s three times and ultracentrifuged. The resultant superna-
tant was subjected to LC-MS/MS analysis to measure the tri-, tetra-, and
pentapeptides.
For additional details, please refer to the Extended Experimental
Procedures.
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